Speaking multiple languages is like exercise for your brain, according to new research. Studies say it can improve multitasking and may even delay Alzheimer’s. The latest on the impact of bilingualism on the brain.
The Vioxx recall is just the latest of several episodes this year that have prompted criticism of the FDA and Senate hearings. A panel talks about the drug approval process, post-marketing safety surveillance, and how the agency’s work affects Americans’ health and safety.
- Dr. Jerry Avorn author of "Powerful Medicines," professor of medicine at Harvard Medical School, and chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital in Boston
- Sen. Charles Grassley (R-Iowa), ranking member of the Senate Finance Committee
- Marc Kaufman reporter on the national desk of "The Washington Post"
- Alan Goldhammer, PhD associate vice president for regulatory affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA)
- Dr. Sandra Kweder deputy director of the FDA's Office of New Drugs
Most Recent Shows
Six heavily armed gunmen stormed a military school in Peshawar, Pakistan killing more than 130 people, mostly teenagers. Pakistani Taliban claimed responsibility for the deadly attack. Please join us for an update on the attack and its implications for the region.
Homeownership has dropped to the lowest rate in 20 years. New research finds renting makes more financial sense for half of current American homeowners. Re-thinking the benefits of buying a house.
The House and Senate passed a spending bill that could cut pensions for a million workers, raise campaign donation limits and roll back Wall Street reforms. We look at what's at stake in the new budget bill.